InsidersTradesSigma
OKYO Pharma Ltd: management transactions · United States · SEC (Form 4)
SEC:okyo-pharma-ltd-ef2250US·SEC (Form 4)Mcap 83M€
Browse the full directors' dealings record of OKYO Pharma Ltd, a listed equity based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). Market capitalisation: €83.4m. The latest transaction was filed on 20 May 2022 — Acquisition. Among the most active insiders: CERRONE GABRIELE M. The full history is accessible without an account.
5
Insider Decl.
0
Thresholds
€789,119
5 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended March 2025 · cache
1.59 €
Analyst consensus
3 analysts7.00 €Target 9.00 €(+466%)13.00 €
Income statement
Net income−4.7 M€0.0% margin
Valuation
PER (forward)-8.0x
Beta-0.05
Balance sheet & cash
Market cap83.4 M€
Total debt2.2 M€
Free Cash Flow−1.8 M€
Profitability & ownership
ROA-104.6%
% insiders30.4%
% institutions20.8%
Last declaration on 20 May 2022
Declarations5 total
Executives▲Purchase◆Signal · 62SEC
€416,6755,800,000 shares@ €0.07180.50% mcap56.2% of flow
Ordinary Shares
SEC:0001493152-22-014552:0·
Ideal exit: 13 Feb 2023 (T+270)
Executives▲Purchase◆Signal · 57SEC
€47,26412,500 shares@ €3.78110.057% mcap100.0% of flow
American Depositary Shares
SEC:0001493152-22-014438:0·
Ideal exit: 13 Feb 2023 (T+270)
Executives▲Purchase◆Signal · 56SEC
€141,79137,500 shares@ €3.78110.17% mcap19.1% of flow
American Depositary Shares
SEC:0001493152-22-014437:0·
Ideal exit: 13 Feb 2023 (T+270)
Executives▲Purchase◆Signal · 52SEC
€91,72525,000 shares@ €3.6690.11% mcap12.4% of flow
American Depositary Shares
SEC:0001493152-22-014299:0·
Ideal exit: 11 Feb 2023 (T+270)
Executives▲Purchase◆Signal · 52SEC
€91,6661,625,000 shares@ €0.05640.11% mcap12.4% of flow
Ordinary Shares
SEC:0001493152-22-014284:0·
Ideal exit: 11 Feb 2023 (T+270)
5 of 5 declarations